Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

A Study of the TheraBionic P1 Device in Breast Cancer

NCT: NCT07218432 · RECRUITING

NCT IDNCT07218432
StatusRECRUITING
Start Date2026-10
Completion2028-06-30

Brief Summary

The goal of this clinical trial is to learn if adding cancer-specific amplitude-modulated radiofrequency electromagnetic field therapy (TheraBionic P1 device) to the treatment of resectable early-stage breast cancer will affect the pathological response.

Frequently Asked Questions

What is A Study of the TheraBionic P1 Device in Breast Cancer?

A Study of the TheraBionic P1 Device in Breast Cancer is a clinical trial registered under NCT07218432. Current status: RECRUITING.

What is the status of NCT07218432?

The current status of NCT07218432 (A Study of the TheraBionic P1 Device in Breast Cancer) is: RECRUITING.

When did A Study of the TheraBionic P1 Device in Breast Cancer start?

A Study of the TheraBionic P1 Device in Breast Cancer started on 2026-10.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑